JP2015205894A5 - - Google Patents

Download PDF

Info

Publication number
JP2015205894A5
JP2015205894A5 JP2015111995A JP2015111995A JP2015205894A5 JP 2015205894 A5 JP2015205894 A5 JP 2015205894A5 JP 2015111995 A JP2015111995 A JP 2015111995A JP 2015111995 A JP2015111995 A JP 2015111995A JP 2015205894 A5 JP2015205894 A5 JP 2015205894A5
Authority
JP
Japan
Prior art keywords
cells
stro
pharmaceutical composition
composition according
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015111995A
Other languages
English (en)
Japanese (ja)
Other versions
JP6499016B2 (ja
JP2015205894A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015205894A publication Critical patent/JP2015205894A/ja
Publication of JP2015205894A5 publication Critical patent/JP2015205894A5/ja
Application granted granted Critical
Publication of JP6499016B2 publication Critical patent/JP6499016B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015111995A 2008-11-20 2015-06-02 膵機能障害の治療または予防方法 Active JP6499016B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19979608P 2008-11-20 2008-11-20
US61/199,796 2008-11-20

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011536703A Division JP5891034B2 (ja) 2008-11-20 2009-11-19 膵機能障害の治療または予防方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017112578A Division JP2017214384A (ja) 2008-11-20 2017-06-07 膵機能障害の治療または予防方法

Publications (3)

Publication Number Publication Date
JP2015205894A JP2015205894A (ja) 2015-11-19
JP2015205894A5 true JP2015205894A5 (https=) 2019-02-28
JP6499016B2 JP6499016B2 (ja) 2019-04-10

Family

ID=42197754

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2011536703A Active JP5891034B2 (ja) 2008-11-20 2009-11-19 膵機能障害の治療または予防方法
JP2015111995A Active JP6499016B2 (ja) 2008-11-20 2015-06-02 膵機能障害の治療または予防方法
JP2017112578A Withdrawn JP2017214384A (ja) 2008-11-20 2017-06-07 膵機能障害の治療または予防方法
JP2019162845A Active JP7051770B2 (ja) 2008-11-20 2019-09-06 膵機能障害の治療または予防方法
JP2021177234A Withdrawn JP2022031662A (ja) 2008-11-20 2021-10-29 膵機能障害の治療または予防方法
JP2023086994A Active JP7751607B2 (ja) 2008-11-20 2023-05-26 膵機能障害の治療または予防方法
JP2025099335A Pending JP2025148353A (ja) 2008-11-20 2025-06-13 膵機能障害の治療または予防方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011536703A Active JP5891034B2 (ja) 2008-11-20 2009-11-19 膵機能障害の治療または予防方法

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2017112578A Withdrawn JP2017214384A (ja) 2008-11-20 2017-06-07 膵機能障害の治療または予防方法
JP2019162845A Active JP7051770B2 (ja) 2008-11-20 2019-09-06 膵機能障害の治療または予防方法
JP2021177234A Withdrawn JP2022031662A (ja) 2008-11-20 2021-10-29 膵機能障害の治療または予防方法
JP2023086994A Active JP7751607B2 (ja) 2008-11-20 2023-05-26 膵機能障害の治療または予防方法
JP2025099335A Pending JP2025148353A (ja) 2008-11-20 2025-06-13 膵機能障害の治療または予防方法

Country Status (10)

Country Link
US (3) US8894972B2 (https=)
EP (2) EP2350266B1 (https=)
JP (7) JP5891034B2 (https=)
KR (2) KR101832497B1 (https=)
CN (3) CN104546912B (https=)
AU (1) AU2009317874B2 (https=)
CA (1) CA2744228C (https=)
DK (1) DK2350266T3 (https=)
ES (2) ES2550795T3 (https=)
WO (1) WO2010057260A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6041456B2 (ja) * 2006-07-12 2016-12-07 メゾブラスト，インコーポレーテッド 過剰新生血管形成の治療
EP2350266B1 (en) * 2008-11-20 2015-07-29 Mesoblast, Inc. Method for treating or preventing a pancreatic dysfunction
CN107141353A (zh) 2009-03-05 2017-09-08 哈佛学院董事会 分泌的aP2及其抑制方法
CA2803641A1 (en) * 2010-07-02 2012-01-05 Mesoblast, Inc. Treatment of t-cell mediated immune disorders
KR101967492B1 (ko) * 2011-05-19 2019-04-09 메소블라스트, 아이엔씨. 비만 및/또는 대사 증후군을 치료하는 방법
WO2012162754A1 (en) 2011-06-03 2012-12-06 Mesoblast, Inc Methods of treating or preventing neurological diseases
KR101786862B1 (ko) * 2011-07-04 2017-10-18 메소블라스트, 아이엔씨. 류마티즘성 질환을 치료 또는 예방하는 방법
AU2012279995C1 (en) 2011-07-06 2019-10-24 Cell Therapy Limited Progenitor cells of mesodermal lineage
CN104098682B (zh) * 2013-04-03 2018-01-02 苏州偲聚生物材料有限公司 多肽、包含该多肽的检测器件和检测试剂盒
SG11201504340YA (en) * 2012-12-12 2015-07-30 Mesoblast Inc Treatment of diseases of endothelial dysfunction and inflammation
US20140314872A1 (en) * 2013-04-22 2014-10-23 Hans Klingemann Methods of Use of Culture Supernatant Obtained from Mesenchymal Stem Cells from Dogs and Cats for Treatment of Organ Dysfunction
CN104714021B (zh) * 2013-12-12 2016-05-25 张曼 尿液凝血酶原蛋白在2型糖尿病合并冠心病中的应用
EP3288584A2 (en) 2015-04-30 2018-03-07 President and Fellows of Harvard College Anti-ap2 antibodies and antigen binding agents to treat metabolic disorders
BR112018076703A2 (pt) * 2016-06-27 2019-04-02 President And Fellows Of Harvard College compostos úteis para tratar distúrbios metabólicos
CA3066733A1 (en) 2017-06-09 2018-12-13 President And Fellows Of Harvard College Method to identify compounds useful to treat dysregulated lipogenesis, diabetes, and related disorders
CN110959579A (zh) * 2019-11-14 2020-04-07 顾隽 患者来源的淋巴瘤免疫缺陷小鼠移植瘤模型的构建方法及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
WO1992001070A1 (en) 1990-07-09 1992-01-23 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce High efficiency packaging of mutant adeno-associated virus using amber suppressions
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
JP3534749B2 (ja) 1991-08-20 2004-06-07 アメリカ合衆国 アデノウイルスが介在する胃腸管への遺伝子の輸送
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
AUPQ147799A0 (en) 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
DE19939781C2 (de) 1999-08-21 2003-06-18 Schott Glas Skulltiegel für das Erschmelzen oder das Läutern von anorganischen Substanzen, insbesondere von Gläsern und Glaskeramiken
WO2004016747A2 (en) * 2002-08-14 2004-02-26 University Of Florida Bone marrow cell differentiation
KR100821128B1 (ko) * 2003-11-04 2008-04-14 가부시키가이샤 바이오마스타 지방 조직으로부터 줄기세포를 생성하는 방법 및 시스템
CA2866468C (en) * 2004-09-24 2019-09-03 Mesoblast, Inc. Generating multipotential expanded mesenchymal precursor cell progeny (memp) from mesenchymal progenitor cells (mpc) and stimulation factor
WO2006108229A1 (en) * 2005-04-12 2006-10-19 Angioblast Systems, Inc. Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
GB0514785D0 (en) * 2005-07-19 2005-08-24 Innovia Films Ltd Sealed ream wrap package and films suitable for forming such packages
JP2009535347A (ja) * 2006-04-28 2009-10-01 テュレーン・ユニバーシティ・ヘルス・サイエンシーズ・センター 糖尿病の治療方法
US20100247491A1 (en) * 2007-02-01 2010-09-30 Christof Westenfelder Potentiation of Stem Cell Homing and Treatment of Organ Dysfunction or Organ Failure
EP2350266B1 (en) 2008-11-20 2015-07-29 Mesoblast, Inc. Method for treating or preventing a pancreatic dysfunction
US9405700B2 (en) 2010-11-04 2016-08-02 Sonics, Inc. Methods and apparatus for virtualization in an integrated circuit

Similar Documents

Publication Publication Date Title
JP2015205894A5 (https=)
Xie et al. Functional dental pulp regeneration: basic research and clinical translation
Molnar et al. Mesenchymal stem cell mechanisms of action and clinical effects in osteoarthritis: a narrative review
Jensen et al. Functionalization of polycaprolactone scaffolds with hyaluronic acid and β-TCP facilitates migration and osteogenic differentiation of human dental pulp stem cells in vitro
Hernández-Monjaraz et al. Mesenchymal stem cells of dental origin for inducing tissue regeneration in periodontitis: a mini-review
de Bakker et al. Canine mesenchymal stem cells: state of the art, perspectives as therapy for dogs and as a model for man
Smojver et al. Mesenchymal stem cells based treatment in dental medicine: a narrative review
Li et al. Improved fat graft survival by different volume fractions of platelet-rich plasma and adipose-derived stem cells
Baru et al. Angiogenesis in regenerative dentistry: are we far enough for therapy?
Woloszyk et al. Influence of the mechanical environment on the engineering of mineralised tissues using human dental pulp stem cells and silk fibroin scaffolds
MA34057B1 (fr) Compositions et methodes pour le diagnostic et le traitement d'une tumeur
Xu et al. Roles of cartilage-resident stem/progenitor cells in cartilage physiology, development, repair and osteoarthritis
Müller et al. Amorphous, smart, and bioinspired polyphosphate nano/microparticles: a biomaterial for regeneration and repair of osteo-articular impairments in-situ
MX2017015037A (es) Composiciones nutritivas que contienen un nivel elevado de inositol y usos de las mismas.
Lee et al. Stem and progenitor cell microenvironment for bone regeneration and repair
Mohd Nor et al. From teeth to therapy: a review of therapeutic potential within the secretome of stem cells from human exfoliated deciduous teeth
EA201790950A1 (ru) Способы и композиции, в частности, для лечения синдрома дефицита внимания
Song et al. Mesenchymal stromal cells in osteoarthritis: evidence for structural benefit and cartilage repair
RU2014146291A (ru) Способ использования сложных эфиров азелаиновой кислоты для модуляции передачи сигналов, медиируемых биологическими молекулами
Liu et al. The involving roles of intrahepatic and extrahepatic stem/progenitor cells (SPCs) to liver regeneration
EA201690005A1 (ru) Состав с модифицированной кинетикой высвобождения
Ning et al. Microfiber-reinforced composite hydrogels loaded with rat adipose-derived stem cells and BMP-2 for the treatment of medication-related osteonecrosis of the jaw in a rat model
Di Vito et al. A review of novel strategies for human periodontal ligament stem cell ex vivo expansion: are they an evidence-based promise for regenerative periodontal therapy?
Svoradova et al. Chicken mesenchymal stem cells and their applications: a mini review
Clerici et al. Endotenon-derived type II tendon stem cells have enhanced proliferative and tenogenic potential